Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce A Perkins

Showing results (191-200 of 247) with videos related to

Pageof 25
Sort By:
Journal of Diabetes and Its Complications|August 6, 2025
Predicting the occurrence of DKA following sodium glucose co-transporter-2 inhibitors: An international cohort studyMichael Fralick, Mats C Højbjerg Lassen, Jagadish Rangrej, et al.
Canadian Journal of Diabetes|July 28, 2024
Prognostic Implications of Diabetic Ketoacidosis in Adults on Long-term Mortality and Diabetes-Related ComplicationsDalton R Budhram, Priya Bapat, Abdulmohsen Bakhsh, et al.
Diabetes Care|March 24, 2016
Commonly Measured Clinical Variables Are Not Associated With Burden of Complications in Long-standing Type 1 Diabetes: Results From the Canadian Study of Longevity in DiabetesAlanna Weisman, Randy Rovinski, Mohammed A Farooqi, et al.
Plos One|November 7, 2015
Diurnal Glycemic Patterns during an 8-Week Open-Label Proof-of-Concept Trial of Empagliflozin in Type 1 DiabetesBruce A Perkins, David Z I Cherney, Nima Soleymanlou, et al.
Diabetes Care|December 15, 2022
Relationships Between the Cumulative Incidences of Long-term Complications in Type 1 Diabetes: The DCCT/EDIC StudyIonut Bebu, Barbara H Braffett, Ian H de Boer, et al.
Canadian Journal of Diabetes|November 30, 2025
Barriers to Diabetic Ketoacidosis Prevention in Adults with Type 1 Diabetes: Implications for Education and Implementation of New Monitoring TechnologiesNatasha J Verhoeff, Wajeeha Cheema, Sara Mojdehi, et al.
Cardiovascular Diabetology|August 14, 2025
Cardiovascular autonomic neuropathy defined by indices of heart rate variability is associated with cardiovascular disease: a longitudinal cohort study of participants with type 1 diabetesBarbara H Braffett, Laure El Ghormli, Catherine Martin, et al.
Journal of the American Society of Nephrology : JASN|August 1, 2009
Urinary peptidome may predict renal function decline in type 1 diabetes and microalbuminuriaMichael L Merchant, Bruce A Perkins, Grzegorz M Boratyn, et al.
Diabetes, Obesity & Metabolism|February 2, 2021
Reducing the need for carbohydrate counting in type 1 diabetes using closed-loop automated insulin delivery (artificial pancreas) and empagliflozin: A randomized, controlled, non-inferiority, crossover pilot trialAhmad Haidar, Jean-Francois Yale, Leif Erik Lovblom, et al.
Diabetes Care|August 24, 2023
Point-of-Care Capillary Blood Ketone Measurements and the Prediction of Future Ketoacidosis Risk in Type 1 DiabetesCimon Song, Sharon Dhaliwal, Priya Bapat, et al.
Pageof 25

Showing results (191-200 of 247) with videos related to

Sort By:
Pageof 25
Journal of Diabetes and Its Complications|August 6, 2025
Predicting the occurrence of DKA following sodium glucose co-transporter-2 inhibitors: An international cohort studyMichael Fralick, Mats C Højbjerg Lassen, Jagadish Rangrej, et al.
Canadian Journal of Diabetes|July 28, 2024
Prognostic Implications of Diabetic Ketoacidosis in Adults on Long-term Mortality and Diabetes-Related ComplicationsDalton R Budhram, Priya Bapat, Abdulmohsen Bakhsh, et al.
Diabetes Care|March 24, 2016
Commonly Measured Clinical Variables Are Not Associated With Burden of Complications in Long-standing Type 1 Diabetes: Results From the Canadian Study of Longevity in DiabetesAlanna Weisman, Randy Rovinski, Mohammed A Farooqi, et al.
Plos One|November 7, 2015
Diurnal Glycemic Patterns during an 8-Week Open-Label Proof-of-Concept Trial of Empagliflozin in Type 1 DiabetesBruce A Perkins, David Z I Cherney, Nima Soleymanlou, et al.
Diabetes Care|December 15, 2022
Relationships Between the Cumulative Incidences of Long-term Complications in Type 1 Diabetes: The DCCT/EDIC StudyIonut Bebu, Barbara H Braffett, Ian H de Boer, et al.
Canadian Journal of Diabetes|November 30, 2025
Barriers to Diabetic Ketoacidosis Prevention in Adults with Type 1 Diabetes: Implications for Education and Implementation of New Monitoring TechnologiesNatasha J Verhoeff, Wajeeha Cheema, Sara Mojdehi, et al.
Cardiovascular Diabetology|August 14, 2025
Cardiovascular autonomic neuropathy defined by indices of heart rate variability is associated with cardiovascular disease: a longitudinal cohort study of participants with type 1 diabetesBarbara H Braffett, Laure El Ghormli, Catherine Martin, et al.
Journal of the American Society of Nephrology : JASN|August 1, 2009
Urinary peptidome may predict renal function decline in type 1 diabetes and microalbuminuriaMichael L Merchant, Bruce A Perkins, Grzegorz M Boratyn, et al.
Diabetes, Obesity & Metabolism|February 2, 2021
Reducing the need for carbohydrate counting in type 1 diabetes using closed-loop automated insulin delivery (artificial pancreas) and empagliflozin: A randomized, controlled, non-inferiority, crossover pilot trialAhmad Haidar, Jean-Francois Yale, Leif Erik Lovblom, et al.
Diabetes Care|August 24, 2023
Point-of-Care Capillary Blood Ketone Measurements and the Prediction of Future Ketoacidosis Risk in Type 1 DiabetesCimon Song, Sharon Dhaliwal, Priya Bapat, et al.
Pageof 25